PCM
MEDP icon

Prelude Capital Management’s Medpace MEDP Stock Holding History

Prelude Capital Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-430
Closed -$242K – 1443
2025
Q4 		$242K Sell
430
-203
-32% -$115K 0.02% 918
2025
Q3 		$325K Sell
633
-132
-17% -$57.6K 0.03% 692
2025
Q2 		$240K Buy
765
+108
+16% +$32.4K 0.02% 722
2025
Q1 		$200K Buy
657
+33
+5% +$11.1K 0.02% 949
2024
Q4 		$207K Sell
624
-583
-48% -$198K 0.01% 979
2024
Q3 		$403K Buy
1,207
+236
+24% +$89.7K 0.02% 717
2024
Q2 		$400K Sell
971
-369
-28% -$146K 0.03% 648
2024
Q1 		$542K Buy
1,340
+571
+74% +$201K 0.03% 606
2023
Q4 		$236K Sell
769
-1,080
-58% -$292K 0.02% 859
2023
Q3 		$448K Sell
1,849
-8,506
-82% -$2.18M 0.03% 506
2023
Q2 		$2.49M Buy
10,355
+2,072
+25% +$430K 0.16% 157
2023
Q1 		$1.56M Buy
8,283
+222
+3% +$45.9K 0.09% 247
2022
Q4 		$1.71M Buy
8,061
+195
+2% +$39K 0.09% 244
2022
Q3 		$1.24M Buy
+7,866
New +$1.26M 0.04% 355
2022
Q2 		– Sell
-4,800
Closed -$785K – 1957
2022
Q1 		$785K Buy
+4,800
New +$791K 0.02% 677
2020
Q4 		– Sell
-46
Closed -$5K – 1698
2020
Q3 		$5K Buy
+46
New +$5.32K ﹤0.01% 1562
2019
Q2 		– Sell
-209
Closed -$12K – 1950
2019
Q1 		$12K Sell
209
-3,145
-94% -$188K ﹤0.01% 1403
2018
Q4 		$178K Buy
3,354
+2,300
+218% +$126K 0.01% 764
2018
Q3 		$63K Sell
1,054
-446
-30% -$24.4K ﹤0.01% 1074
2018
Q2 		$65K Buy
+1,500
New +$60.6K ﹤0.01% 1061
2018
Q1 		– Sell
-3,693
Closed -$134K – 1638
2017
Q4 		$134K Hold
3,693
– – 0.01% 716
2017
Q3 		$118K Sell
3,693
-800
-18% -$24.4K 0.01% 834
2017
Q2 		$130K Buy
4,493
+2,993
+200% +$84K 0.01% 709
2017
Q1 		$45K Buy
+1,500
New +$48.4K ﹤0.01% 1024

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Prelude Capital Management's MEDP Position: Q1 2026 in Review

Prelude Capital Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 430 shares — an estimated $242K sold.

Prelude Capital Management first reported a position in MEDP in Q1 2017 and held it in 24 quarters. The position peaked at $2.49M in Q2 2023. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Prelude Capital Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Prelude Capital Management sold 430 Medpace shares in Q1 2026, an estimated $242K.
  • Prelude Capital Management first reported a position in Medpace in Q1 2017 and held it in 24 quarters.
  • Prelude Capital Management's Medpace position peaked at $2.49M in Q2 2023.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.